/Companies

Civitas Therapeutics

Chelsea, US · Founded 2009 · 9 known investors

Find your way into Civitas Therapeutics

Each arrow is one introduction. Sign up to fill in the first one.

290 people can intro you to MARK

Ask Milton H. Werner to introduce you to MARK IWICKI

You →Milton · together at Inhibikase Therapeutics →MARK

290 people can intro you to MARTIN

Ask Jamie Chen to introduce you to MARTIN FREED

You →Jamie · together at Solid Biosciences →MARTIN

Sign up to find every way you can get introduced to Civitas Therapeutics

  • Your email: who you already know at Civitas Therapeutics, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Civitas Therapeutics team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Founders & leadership

Civitas Therapeutics was founded in 2009 by RICHARD BATYCKY and GLENN BATCHELDER.

RB
RICHARD BATYCKYCo-founder
GB
GLENN BATCHELDERCo-founder
BS
BRYAN STUARTChief Business Officer2012–2014Chief Executive Officer at Atavistik Bio
MIMARK IWICKI
MARK IWICKIPresident and Chief Executive Officer2014–2014Mark Iwicki has three decades of experience in pharmaceutical development and commercialization across multiple therapeutic areas. He has held CEO positions at Inhibikase Therapeutics, Kala Bio, Civitas Therapeutics, Blend Therapeutics, and Sunovion.
MFMARTIN FREED
MARTIN FREEDExecutiveMartin Freed is an executive officer at Civitas Therapeutics with over three decades of pharmaceutical and biotechnology experience spanning clinical development, drug development across multiple therapeutic areas, and leadership roles in both large and small companies.

Board

RHROB HOPFNER
ROB HOPFNERBoard2013–2014Managing Director at Pivotal Life Sciences
BJ
BLAIR JACKSONBoard director
RSRAJEEV SHAH
RAJEEV SHAHBoard directorManaging Director at RA Capital
TSTIM SHANNON
TIM SHANNONBoard directorGeneral Partner at Canaan Partners
DH
DAVID HIRSCHBoard director
TS
TIMOTHY S. NELSONBoard director
RR
ROBERT ROCHEBoard director

Investors · 9

Also in the syndicate · 2

AlkermesAlkermes plc

Funding

SEC filings, press & company announcements

$55.3M disclosed across 1 of 3 rounds · 2011–2014

▶$55.3MraisedAug 2014 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • ROB HOPFNERDirector
  • BLAIR JACKSONDirector
  • BRYAN STUARTExecutive Officer
  • TIMOTHY S. NELSONDirector
  • RAJEEV SHAHDirector
  • MARK IWICKIExecutive Officer, Director
  • RICHARD BATYCKYExecutive Officer
  • TIM SHANNONDirector
  • GLENN BATCHELDERDirector
  • DAVID HIRSCHDirector
  • MARTIN FREEDExecutive Officer
  • ROBERT ROCHEDirector
  • AIDAN KINGDirector
  • ANDREA FRANZExecutive Officer
  • MARY TAYLORExecutive Officer
Offering amount
$55.3M
Amount sold
$55.3M
First sale
Aug 2014
Incorporated
Corporation, Delaware, 2009
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

3 people who came through Civitas Therapeutics went on to found or lead other companies.

In the news

Frequently asked questions

Who founded Civitas Therapeutics?
Civitas Therapeutics was founded by RICHARD BATYCKY, GLENN BATCHELDER in 2009.
Who are Civitas Therapeutics's investors?
Civitas Therapeutics's investors include Canaan Partners, Longitude Capital, Sofinnova Ventures, Bay City Capital, Fountain Healthcare Partners, OrbiMed, RA Capital.
How much funding has Civitas Therapeutics raised?
Civitas Therapeutics has disclosed $55.3M raised across 1 of its 3 known rounds.
Where is Civitas Therapeutics headquartered?
Civitas Therapeutics is headquartered in Chelsea, US.